All Stories

  1. Cryptorchidism is frequently associated with testicular dysfunction
  2. Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients
  3. Assessment of testicular function in boys and adolescents
  4. Nathalie Josso, MD, PhD, 1934–2022
  5. Identification of a Novel Variant in Myelin Regulatory Growth Factor by Next-Generation Sequencing Led to the Detection of a Clinically Inapparent Congenital Heart Defect in a Patient with a 46,XY Disorder of Sex Development
  6. Taming Idiopathic Central Precocious Puberty: High Frequency of Imprinting Disorders in Familial Forms
  7. Considerations when treating male pubertal delay pharmacologically
  8. Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
  9. Delayed Puberty Due to a WDR11 Truncation at Its N-Terminal Domain Leading to a Mild Form of Ciliopathy Presenting With Dissociated Central Hypogonadism: Case Report
  10. AMH Regulation by Steroids in the Mammalian Testis: Underlying Mechanisms and Clinical Implications
  11. Next-Generation Sequencing as First-Line Diagnostic Test in Patients With Disorders of Sex Development?
  12. Are We Prepared to Abandon the Idea of Sex Binarism? A Biomedical Perspective
  13. Genetics of reproductive endocrinology
  14. Recent advancement in the treatment of boys and adolescents with hypogonadism
  15. Disorders of Sex Development of Adrenal Origin
  16. Up-to-Date Clinical and Biochemical Workup of the Child and the Adolescent with a Suspected Disorder of Sex Development
  17. Clinical tools in the diagnosis of disorders of sex development: a switch from the hormonal to the genetics laboratory?
  18. Herramientas clínicas en el diagnóstico del desarrollo sexual anómalo: ¿del análisis hormonal al análisis genético?
  19. Growth, puberty and testicular function in boys born small for gestational age with a nonspecific disorder of sex development
  20. Diagnosis of Male Central Hypogonadism During Childhood
  21. AMH and AMHR2 Involvement in Congenital Disorders of Sex Development
  22. Noncanonical Wnt Signaling in the Integrity of the Blood-Testis Barrier and Sperm Release
  23. Gonadectomy in conditions affecting sex development: a registry-based cohort study
  24. Development and Validation of a Prediction Rule for Growth Hormone Deficiency Without Need for Pharmacological Stimulation Tests in Children With Risk Factors
  25. Expression of acid-labile subunit (ALS) in developing and adult zebrafish and its role in dorso-ventral patterning during development
  26. The Role of Androgen Signaling in Male Sexual Development at Puberty
  27. Editorial: Puberty: Recent advancements in its physiology and the management of its disorders
  28. Regulation of meiosis initiation in the mammalian testis: novel aspects
  29. Molecular mechanisms underlying AMH elevation in hyperoestrogenic states in males
  30. What Does AMH Tell Us in Pediatric Disorders of Sex Development?
  31. Síndrome de osteoporosis-pseudoglioma: a propósito de un caso pediátrico de osteoporosis primaria
  32. Androgen Treatment in Adolescent Males With Hypogonadism
  33. Male Hypogonadism and Disorders of Sex Development
  34. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI)
  35. p.R209H GH1 variant challenges short stature assessment
  36. Molecular Characterization of XX Maleness
  37. Safety of standardised treatments for haematologic malignancies as regards to testicular endocrine function in children and teenagers
  38. CYP26B1 declines postnatally in Sertoli cells independently of androgen action in the mouse testis
  39. A homozygous mutation in the highly conserved Tyr60 of the mature IGF1 peptide broadens the spectrum of IGF1 deficiency
  40. Importance of the Androgen Receptor Signaling in Gene Transactivation and Transrepression for Pubertal Maturation of the Testis
  41. Hypogonadism in Pediatric Health: Adult Medicine Concepts Fail
  42. Importance of the Androgen Receptor Signalling in Gene Transactivation and Transrepression for Pubertal Maturation of the Testis
  43. A mutation inactivating the distal SF1 binding site on the human anti-Müllerian hormone promoter causes persistent Müllerian duct syndrome
  44. Paediatric and adult-onset male hypogonadism
  45. Comparing the role of anti-Müllerian hormone as a marker of FSH action in male and female fertility
  46. Androgens downregulate anti-Müllerian hormone promoter activity in the Sertoli cell through the androgen receptor and intact steroidogenic factor 1 sites†
  47. Clinical and Etiological Aspects of Gynecomastia in Adult Males: A Multicenter Study
  48. Anti-Müllerian Hormone and Testicular Function in Prepubertal Boys With Cryptorchidism
  49. Anti-Müllerian Hormone Deficiency and Resistance
  50. Commentary on sperm DNA fragmentation testing clinical guideline
  51. Importance of Serum Testicular Protein Hormone Measurement in the Assessment of Disorders of Sex Development
  52. Characterization of four Latin American families confirms previous findings and reveals novel features of acid-labile subunit deficiency
  53. Puberty arises with testicular alterations and defective AMH expression in rams prenatally exposed to testosterone
  54. Juan Jorge Heinrich, MD, PhD, 1937–2016
  55. Global Application of the Assessment of Communication Skills of Paediatric Endocrinology Fellows in the Management of Differences in Sex Development Using the ESPE E-Learning.Org Portal
  56. Most Cleaved Anti-Müllerian Hormone Binds Its Receptor in Human Follicular Fluid but Little Is Competent in Serum
  57. 46,XX ovotesticular DSD associated with aSOX3gene duplication in aSRY-negative boy
  58. Assessment of pathogenicity of natural IGFALS gene variants by in silico bioinformatics tools and in vitro functional studies
  59. Disorders of Sex Development with Testicular Differentiation in SRY-Negative 46,XX Individuals: Clinical and Genetic Aspects
  60. Diagnosis and Treatment of Disorders of Sexual Development∗
  61. Hormonal Changes in Childhood and Puberty
  62. Compensatory function of the remaining testis is dissociated in boys and adolescents with monorchidism
  63. Fertility Issues in Disorders of Sex Development
  64. Hypogonadotropic Hypogonadism in Infants with Congenital Hypopituitarism: A Challenge to Diagnose at an Early Stage
  65. When hormone defects cannot explain it: Malformative disorders of sex development
  66. Spreading the Clinical Window for Diagnosing Fetal-Onset Hypogonadism in Boys
  67. Mini-puberty and true puberty: Differences in testicular function
  68. Fertility Issues in the Management of Patients with Disorders of Sex Development
  69. Testicular function during adolescence in boys with type 1 diabetes mellitus (T1D): absence of hypogonadism and differences in endocrine profile at the beginning and end of puberty
  70. Prediction of Reproductive Outcomes According to Different Serum Anti-Müllerian Hormone Levels in Females Undergoing Intracystoplasmic Sperm Injection
  71. The prepubertal testis
  72. Prenatal testosterone programming: ontogeny of changes in testis of fetal and prepubertal male sheep
  73. Anti-Mullerian hormone: a Sertoli cell hormone that can be used as a predictor of male hypogonadism
  74. Anti-Müllerian Hormone: A Valuable Addition to the Toolbox of the Pediatric Endocrinologist
  75. HeterozygousIGFALSGene Variants in Idiopathic Short Stature and Normal Children: Impact on Height and the IGF System
  76. Accelerated early pubertal progression, ovarian morphology, and ovarian function in prospectively followed low birth weight (LBW) girls
  77. Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
  78. Serum AMH level can predict the risk of cycle cancellation and the chances of good ovarian response, independently of patient's age or FSH
  79. Early Orchiopexy to Prevent Germ Cell Loss during Infancy in Congenital Cryptorchidism
  80. Altered testicular development as a consequence of increase number of sertoli cell in male lambs exposed prenatally to excess testosterone
  81. Testicular Anti-Müllerian Hormone: Clinical Applications in DSD
  82. Decline in serum antimüllerian hormone due to androgen action in early puberty in males
  83. Differential Regulation of Ovarian Anti-Müllerian Hormone (AMH) by Estradiol through α- and β-Estrogen Receptors
  84. Gonadotrophin secretion pattern in anorchid boys from birth to pubertal age: pathophysiological aspects and diagnostic usefulness
  85. Disorders of Sex Development and Hypogonadism: Genetics, Mechanism, and Therapies
  86. Clinical Presentation of Klinefelter's Syndrome: Differences According to Age
  87. Sertoli cell markers in the diagnosis of paediatric male hypogonadism
  88. New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a Sertoli cell marker
  89. Early onset of primary hypogonadism revealed by serum anti-Müllerian hormone determination during infancy and childhood in trisomy 21
  90. SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1
  91. FSH and Its Second Messenger cAMP Stimulate the Transcription of Human Anti-Müllerian Hormone in Cultured Granulosa Cells
  92. Normal male sexual differentiation and aetiology of disorders of sex development
  93. Are Klinefelter boys hypogonadal?
  94. Elevated anti-Müllerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus
  95. Prenatal testosterone excess alters Sertoli and germ cell number and testicular FSH receptor expression in rams
  96. Basal Follicle-Stimulating Hormone and Peak Gonadotropin Levels after Gonadotropin-Releasing Hormone Infusion Show High Diagnostic Accuracy in Boys with Suspicion of Hypogonadotropic Hypogonadism
  97. Origin and evolution of somatic cell testicular tumours in transgenic mice
  98. Anti-Müllerian Hormone and Sertoli Cell Function in Paediatric Male Hypogonadism
  99. Ontogeny of the androgen receptor expression in the fetal and postnatal testis: Its relevance on Sertoli cell maturation and the onset of adult spermatogenesis
  100. Anti-Müllerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus
  101. Normal and abnormal female sexual differentiation
  102. FSH and bFGF stimulate the production of glutathione in cultured rat Sertoli cells
  103. Lack of Androgen Receptor Expression in Sertoli Cells Accounts for the Absence of Anti-Mullerian Hormone Repression during Early Human Testis Development
  104. Lack of Androgen Receptor Expression in Sertoli Cells Accounts for the Absence of Anti-Mullerian Hormone Repression during Early Human Testis Development
  105. Lack of Androgen Receptor Expression in Sertoli Cells accounts for the Absence of Anti-Mullerian Hormone Repression during Early Human Testis Development
  106. Klinefelter Syndrome and Cryptorchidism
  107. Physiological Androgen Insensitivity of the Fetal, Neonatal, and Early Infantile Testis Is Explained by the Ontogeny of the Androgen Receptor Expression in Sertoli Cells
  108. Pituitary and Testicular Function in Sons of Women with Polycystic Ovary Syndrome from Infancy to Adulthood
  109. Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
  110. Establishment of testicular endocrine function impairment during childhood and puberty in boys with Klinefelter syndrome
  111. Activation of Melanocortin 4 Receptors Reduces the Inflammatory Response and Prevents Apoptosis Induced by Lipopolysaccharide and Interferon-γ in Astrocytes
  112. Predictive Value of Anatomical Findings and Karyotype Analysis in the Diagnosis of Patients with Disorders of Sexual Development
  113. Seminiferous tubule function in delayed-onset X-linked adrenal hypoplasia congenita associated with incomplete hypogonadotrophic hypogonadism
  114. Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune–Albright syndrome
  115. Time Course of the Serum Gonadotropin Surge, Inhibins, and Anti-Müllerian Hormone in Normal Newborn Males during the First Month of Life
  116. Mitotic activity of Sertoli cells in adult human testis: an immunohistochemical study to characterize Sertoli cells in testicular cords from patients showing testicular dysgenesis syndrome
  117. Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias
  118. Anti-Müllerian hormone in disorders of sex determination and differentiation
  119. Testicular Anti-Müllerian Hormone Secretion Is Stimulated by Recombinant Human FSH in Patients with Congenital Hypogonadotropic Hypogonadism
  120. Differentiation markers of Sertoli cells and germ cells in fetal and early postnatal human testis
  121. Subcellular and Molecular Mechanisms Regulating Anti-Müllerian Hormone Gene Expression in Mammalian and Nonmammalian Species
  122. Subcellular and Molecular Mechanisms Regulating Anti-Müllerian Hormone Gene Expression in Mammalian and Nonmammalian Species
  123. Altered serum profile of inhibin B, Pro-alphaC and anti-Mullerian hormone in prepubertal and pubertal boys with varicocele
  124. AMH/MIS: what we know already about the gene, the protein and its regulation
  125. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans
  126. Follicle-Stimulating Hormone Increases Testicular Anti-Müllerian Hormone (AMH) Production through Sertoli Cell Proliferation and a Nonclassical Cyclic Adenosine 5′-Monophosphate-Mediated Activation of the AMH Gene
  127. Anti-Müllerian Hormone
  128. Age dependent changes in plasma anti-Müllerian hormone concentrations in the bovine male, female, and freemartin from birth to puberty: relationship between testosterone production and influence on sex differentiation
  129. Altered expression of connexins 26 and 43 in Sertoli cells in seminiferous tubules infiltrated with carcinoma-in-situ or seminoma
  130. Aetiological diagnosis of male sex ambiguity: a collaborative study
  131. Sertoli Cell Proliferations of the Infantile Testis
  132. Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Mullerian Hormone in Transgenic Mice
  133. Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Müllerian Hormone in Transgenic Mice
  134. DIFERENCIACIÓN SEXUAL EMBRIO-FETAL: DE LAS MOLÉCULAS A LA ANATOMIA
  135. Macroorchidism due to Autonomous Hyperfunction of Sertoli Cells and Gs  Gene Mutation: An Unusual Expression of McCune-Albright Syndrome in a Prepubertal Boy
  136. Anti-Müllerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors
  137. Assessment of seminiferous tubule function (anti-müllerian hormone)
  138. L'intérêt du dosage de l'hormone anti-mullérienne en clinique humaine
  139. Detection of Minimal Levels of Serum Anti-Mullerian Hormone during Follow-Up of Patients with Ovarian Granulosa Cell Tumor by Means of a Highly Sensitive Enzyme-Linked Immunosorbent Assay
  140. Antimüllerian Hormone in Patients with Hypogonadotropic Hypogonadism
  141. Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia
  142. Presence of anti-Müllerian hormone correlates with absence of laminin α5 chain in differentiating rat testis and ovary
  143. Evaluation of Gonadal Function in 107 Intersex Patients by Means of Serum Antimullerian Hormone Measurement
  144. Retained Müllerian Ducts
  145. Reversion of the differentiated phenotype and maturation block in Sertoli cells in pathological human testis
  146. The role of anti-Müllerian hormone in gonadal development
  147. Endocrine, Paracrine and Cellular Regulation of Postnatal Anti-Müllerian Hormone Secretion by Sertoli Cells
  148. Embryology and endocrinology of genital development
  149. Inhibin B Is the Major Form of Inhibin/Activin Family Secreted by Granulosa Cell Tumors
  150. Inhibin B Is the Major Form of Inhibin/Activin Family Secreted by Granulosa Cell Tumors
  151. Receptors for anti-Müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation
  152. A mouse Sertoli cell line expressing anti-Müllerian hormone and its type II receptor
  153. Clinical aspects and molecular genetics of the persistent Mullerian duct syndrome
  154. A 27 base-pair deletion of the anti-mullerian type II receptor gene is the most common cause of the persistent mullerian duct syndrome
  155. Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent Müllerian ducts in a Turkish boy born to consanguineous parents
  156. Genetic mechanisms of sex differentiation
  157. Antimullerian Hormone As a Serum Marker of Granulosa Cell Tumors of the Ovary
  158. Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: Comparative study with serum α-inhibin and estradiol
  159. Morphometric study of the testicular interstitial tissue of the monkey Cebus apella during postnatal development
  160. Testicular Steroidogenesis in the Cebus Monkey throughout Postnatal Development1
  161. Testicular degeneration in three patients with the persistent müllerian duct syndrome
  162. Testicular degeneration in three patients with the persistent M�llerian duct syndrome
  163. La cellule de Sertoli, une cellule endocrine
  164. Anti-mullerian hormone in children with androgen insensitivity
  165. Molecular genetics of the persistent Mullerian duct syndrome: a study of 19 families
  166. Anti-mullerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development
  167. Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.
  168. Is infancy a quiescent period of testicular development? Histological, morphometric, and functional study of the seminiferous tubules of the cebus monkey from birth to the end of puberty
  169. Is infancy a quiescent period of testicular development? Histological, morphometric, and functional study of the seminiferous tubules of the cebus monkey from birth to the end of puberty.